Joint Care

Fidia offers integrated solutions for the treatment of cartilage and tendon pathologies, based on different approaches: peri-articular therapy (both oral and topical) and intra-articular administration of hyaluronic acid, thus offering an exciting array of therapeutic options for the treatment of osteoarthritis and cartilage damage also subsequent to joint overuse, e.g. sport-related traumatic events.

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.